Mechanistically, restricted glucose consumption by T cells in a mouse sarcoma model led to reduced activity of the mammalian target of rapamycin (mTOR), which in turn led to decreased IFN-γ production and glycolytic capacity (39). Here, MTOR is linked to sarcoma.